Veradigm RxTruePrice Helps Drive Higher Medication Adherence
Veradigm Inc. (MDRX)
Last veradigm inc. earnings: 3/2 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.allscripts.com
Company Research
Source: Business Wire
Allscripts business unit addresses need for better patient medication adherence through pricing transparency CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions (NASDAQ: MDRX) and its payer and life science business unit, Veradigm™, announced its findings on the impact of Veradigm’s RxTruePrice™, a solution designed to address patient challenges resulting in them foregoing, discontinuing or substituting their prescribed medication due to cost and a lack of prescription drug price transparency.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200312005092/en/Recent studies have revealed alarming statistics surrounding low medication adherence. For example, 33% of patients have purposely missed filling a prescription due to its prohibitive cost.1 And nearly 6% of patients have skipped taking their medications three times or more.1Patient outcomes may improve if it were easier to ensure patients stay on their prescribed
Show less
Read more
Impact Snapshot
Event Time:
MDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDRX alerts
High impacting Veradigm Inc. news events
Weekly update
A roundup of the hottest topics
MDRX
News
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Regard Hits Milestone of Catching Five Million Medical Conditions [Yahoo! Finance]Yahoo! Finance
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care PracticesBusiness Wire
- Veradigm Inc. (NASDAQ: MDRX) had its price target raised by analysts at Stephens from $7.00 to $13.00. They now have an "equal weight" rating on the stock.MarketBeat
MDRX
Analyst Actions
- 1/31/25 - Stephens & Co.
MDRX
Sec Filings
- 2/14/25 - Form SCHEDULE
- 1/30/25 - Form 8-K
- 1/2/25 - Form 8-K
- MDRX's page on the SEC website